 |
|
Epstein-Barr Virus-Associated Antigens in Nasopharyngeal CarcinomaRelation to Clinical Course of American Patients
Harvey L. Coates, MB;
Gary R. Pearson, PhD;
H. Bryan Neel, III, MD, PhD;
Louis H. Weiland, MD
Arch Otolaryngol. 1978;104(8):427-430.
Abstract
• Thirty-five sera from American patients with nasopharyngeal carcinoma were examined for Epstein-Barr virus (EBV)-associated antigens and compared with 85 sera from patients with other head and neck cancers, 80 sera from patients with lymphoma, and 47 sera from healthy control subjects. There was a definite correlation between the presence of nasopharyngeal carcinoma and the level of antibody titers to EBV. In particular, two tests that detected antibody to early antigen and antibody to viral capsid antigen in the serum IgA fraction were highly specific for the presence of nasopharyngeal carcinoma. There was a significant decrease in these antibody titers with clinical remission of the disease in treated patients with nasopharyngeal carcinoma. Clinically, these tests should have important application in the management and follow-up of patients with nasopharyngeal carcinoma.
(Arch Otolaryngol 104:427-430, 1978)
Author Affiliations
From the Mayo Clinic and Mayo Foundation, Rochester, Minn.
Footnotes
Accepted for publication Nov 24, 1977.
Read before the meeting of the American Society for Head and Neck Surgery, Boston, May 11, 1977.
Reprint requests to Section of Publications, Mayo Clinic, 200 First St SW, Rochester, MN 55901 (Dr Coates).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Epstein-Barr Virus Antibody Titers in Cancer of the Head and Neck
Callaghan et al.
Arch Otolaryngol Head Neck Surg 1983;109:781-784.
ABSTRACT
|
